Physician profile
Mary Vrabec
NPI 1447387444
$2,571.55
in general payments reported to CMS, 2019-2025
33 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $245 · 2021: $439 · 2022: $352 · 2023: $474 · 2024: $233 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $536.07 | 2019-2024 | Ubrelvy, Vraylar, Lo Loestrin Fe |
| Novo Nordisk INC | $428.56 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.64 | 2019-2024 | Jardiance |
| Astellas Pharma US INC | $140.70 | 2019-2023 | Myrbetriq, Veozah |
| Lilly USA, LLC | $135.53 | 2019-2025 | Mounjaro, Zepbound |
| Amgen INC. | $114.37 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $101.91 | 2019-2025 | Airsupra |
| Merck Sharp & Dohme LLC | $76.90 | 2019-2025 | Capvaxive, Gardasil 9 |
| Pfizer INC. | $68.79 | 2019-2025 | |
| Glaxosmithkline, LLC. | $67.26 | 2019-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Amarin Pharma, INC. | $65.85 | 2019-2021 | |
| Exact Sciences Corporation | $60.23 | 2023-2024 | Cologuard Collection Kit |
| Amneal Pharmaceuticals LLC | $58.88 | 2021-2023 | Unithroid |
| Kowa Pharmaceuticals America, INC. | $58.79 | 2019-2021 | |
| Allergan, INC. | $57.30 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $52.23 | 2019-2024 | Xarelto |
| Hologic Sales and Service, LLC | $47.32 | 2021-2024 | Thinprep 2000 Processor, Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.55 | 2022 | |
| Sanofi Pasteur INC. | $34.28 | 2019-2020 | |
| Dynavax Technologies Corporation | $26.99 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $26.56 | 2022 | |
| Bausch Health US, LLC | $24.69 | 2022 | |
| Ethicon US, LLC | $22.35 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $21.77 | 2021 | |
| Sunovion Pharmaceuticals INC. | $20.04 | 2022 | |
| Shire North American Group INC | $19.80 | 2019 | |
| Grifols USA, LLC | $19.26 | 2019 | |
| Dexcom, INC. | $18.74 | 2023 | Dexcom G6 Transmitter |
| Therapeuticsmd, INC. | $17.58 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.50 | 2025 | Nuzyra |
| Alexion Pharmaceuticals, INC. | $15.51 | 2019 | |
| Seqirus USA INC | $14.41 | 2019 | |
| Eisai INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Vrabec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.